| Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the … C Théry, KW Witwer, E Aikawa, MJ Alcaraz, JD Anderson, ... Journal of extracellular vesicles 7 (1), 1535750, 2018 | 8262 | 2018 |
| Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila C Burnett, S Valentini, F Cabreiro, M Goss, M Somogyvári, MD Piper, ... nature 477 (7365), 482-485, 2011 | 751 | 2011 |
| Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons JA Parker, M Arango, S Abderrahmane, E Lambert, C Tourette, H Catoire, ... Nature genetics 37 (4), 349-350, 2005 | 631 | 2005 |
| De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia J Gauthier, N Champagne, RG Lafrenière, L Xiong, D Spiegelman, ... Proceedings of the National Academy of Sciences 107 (17), 7863-7868, 2010 | 430 | 2010 |
| SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis R Luthi-Carter, DM Taylor, J Pallos, E Lambert, A Amore, A Parker, ... Proceedings of the National Academy of Sciences 107 (17), 7927-7932, 2010 | 387 | 2010 |
| C. elegans neurons jettison protein aggregates and mitochondria under neurotoxic stress I Melentijevic, ML Toth, ML Arnold, RJ Guasp, G Harinath, KC Nguyen, ... Nature 542 (7641), 367-371, 2017 | 335 | 2017 |
| Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death JA Parker, JB Connolly, C Wellington, M Hayden, J Dausset, C Neri Proceedings of the National Academy of Sciences 98 (23), 13318-13323, 2001 | 285 | 2001 |
| Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase M Borrell-Pagès, JM Canals, FP Cordelières, JA Parker, JR Pineda, ... The Journal of clinical investigation 116 (5), 1410-1424, 2006 | 262 | 2006 |
| The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis S Holbert, I Denghien, T Kiechle, A Rosenblatt, C Wellington, MR Hayden, ... Proceedings of the National Academy of Sciences 98 (4), 1811-1816, 2001 | 258 | 2001 |
| Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation AT Van Der Goot, W Zhu, RP Vázquez-Manrique, RI Seinstra, K Dettmer, ... Proceedings of the National Academy of Sciences 109 (37), 14912-14917, 2012 | 221 | 2012 |
| Revolution of Alzheimer precision neurology. Passageway of systems biology and neurophysiology H Hampel, N Toschi, C Babiloni, F Baldacci, KL Black, ALW Bokde, ... Journal of Alzheimer's Disease 64 (s1), S47-S105, 2018 | 145 | 2018 |
| Marked phenotypic heterogeneity associated with expansion of a CAG repeat sequence at the spinocerebellar ataxia 3/Machado-Joseph disease locus G Cancel, N Abbas, G Stevanin, A Dürr, H Chneiweiss, C Néri, ... American journal of human genetics 57 (4), 809, 1995 | 145 | 1995 |
| Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease A Vergallo, L Mégret, S Lista, E Cavedo, H Zetterberg, K Blennow, ... Alzheimer's & Dementia 15 (6), 764-775, 2019 | 135 | 2019 |
| Cdc42-interacting protein 4 binds to huntingtin: neuropathologic and biological evidence for a role in Huntington's disease S Holbert, A Dedeoglu, S Humbert, F Saudou, RJ Ferrante, C Néri Proceedings of the National Academy of Sciences 100 (5), 2712-2717, 2003 | 107 | 2003 |
| Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington's disease mice M Achour, S Le Gras, C Keime, F Parmentier, FX Lejeune, AL Boutillier, ... Human molecular genetics 24 (12), 3481-3496, 2015 | 103 | 2015 |
| Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1 H Catoire, MY Pasco, A Abu-Baker, S Holbert, C Tourette, B Brais, ... Human molecular genetics 17 (14), 2108-2117, 2008 | 100 | 2008 |
| AMPK activation protects from neuronal dysfunction and vulnerability across nematode, cellular and mouse models of Huntington's disease RP Vázquez-Manrique, F Farina, K Cambon, M Dolores Sequedo, ... Human molecular genetics 25 (6), 1043-1058, 2016 | 98 | 2016 |
| Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints E Cavedo, PA Chiesa, M Houot, MT Ferretti, MJ Grothe, SJ Teipel, S Lista, ... Alzheimer's & Dementia 14 (9), 1204-1215, 2018 | 86 | 2018 |
| The Oxygen Paradox, the French Paradox, and age-related diseases JMS Davies, J Cillard, B Friguet, E Cadenas, J Cadet, R Cayce, ... GeroScience 39, 499-550, 2017 | 86 | 2017 |
| CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington’s disease R Kacher, A Lamazière, N Heck, V Kappes, C Mounier, G Despres, ... Brain 142 (8), 2432-2450, 2019 | 85 | 2019 |
Michael HaydenKillam Professor, University of British ColumbiaVerified email at cmmt.ubc.ca
